New trial tests which immunotherapy combo best battles melanoma before surgery
NCT ID NCT06794775
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two different immunotherapy treatments given before surgery for stage III melanoma that can be removed. One group gets a single drug (PD-1 blocker), the other gets a two-drug combo (PD-1 and CTLA-4 blockers). The combo may work better but also has more side effects. About 128 adults with resectable stage III melanoma will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA STAGE III are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Karolinska University Hospital
RECRUITINGStockholm, Sweden
-
Sahlgrenska University Hospital
RECRUITINGGothenburg, Sweden
-
Skane University Hospital
RECRUITINGLund, Sweden